BETA

13 Amendments of Davor Ivo STIER related to 2014/2204(INI)

Amendment 13 #
Motion for a resolution
Recital B
B. whereas people are still being infected with the virus in many parts of Guinea and Sierra Leone, while in Liberia the fact that there have been no new cases over the last month allows one to be cautiously optimistic that the worst may be overWHO has declared Liberia free of Ebola virus transmission on 9 May ;
2015/05/28
Committee: DEVE
Amendment 28 #
Draft opinion
Recital D
D. whereas the worst-hit countries have received someignificant assistance from the international community, but foreign governments have focused primarily on financing or building Ebola case- management structures, leaving it up to national authorities, local healthcare staff and NGOs to staff them;
2015/02/12
Committee: ENVI
Amendment 31 #
Draft opinion
Recital D a (new)
Da. whereas the European Union, together with its Member states, has made available more than €1.2 billion in financial aid to help contain the outbreak of Ebola virus disease in West Africa;
2015/02/12
Committee: ENVI
Amendment 33 #
Draft opinion
Recital D b (new)
Db. whereas the European Commission has been actively engaged from the very start of the outbreak, has been scaling up its response to the epidemic and monitors the situation through its Emergency response Coordination Centre which serves for the coordination of EU assistance and under the authority of the EU Ebola Coordinator Christos Stylianides;
2015/02/12
Committee: ENVI
Amendment 35 #
Draft opinion
Recital D c (new)
Dc. whereas the activation of the EU Civil Protection Mechanism has facilitated rapid, coordinated deployment of emergency supplies and experts offered by the Member States;
2015/02/12
Committee: ENVI
Amendment 47 #
Motion for a resolution
Recital H a (new)
Ha. whereas the European Union, together with its Member States, has made available more than 1.39 billion euros to help contain the outbreak of Ebola virus disease in West Africa;
2015/05/28
Committee: DEVE
Amendment 57 #
Draft opinion
Paragraph 4
4. Remains deeply concerned about the heavy toll of EVD on women and girls, and believes that failure to address gender- specific issues will have a negative impact on the prospects for long-term recoveryit is crucial to address the root causes of women being more exposed to EVD, in order to ensure long-term recovery, as well as increased level of equality between women and men in affected countries.
2015/02/06
Committee: FEMM
Amendment 76 #
Draft opinion
Paragraph 2
2. Requires the Member States and the Commission to coordinate and strengthen medical research and the production of efficient medicines and vaccines against Ebola, and to advance the necessary clinical trials for existing candidate treatments; welcomes in this regard the fact that the Commission, together with the European pharmaceutical industry, is funding eight research projects aiming to develop vaccines and rapid diagnostic tests with over 200 million Euro;
2015/02/12
Committee: ENVI
Amendment 81 #
Motion for a resolution
Paragraph 1
1. Criticises the international community's failure to react properly, or at all, during the first few months of the crisis; points out that although the EC was engaged from the very start of the crisis, the response of the Member States has been slow in the beginning; welcomes and encourages in this regard the ongoing scaling-up of the EU and its Member States’ financial commitment in the areas of humanitarian and development aid, logistics and research to respond to the crisis;
2015/05/28
Committee: DEVE
Amendment 87 #
Draft opinion
Paragraph 3
3. Considers that the response of the Member States and the Commission has been slow and insufficient, and that financial support was shy and did not respond to the severity of the alerts that NGOs such as Médecins Sans Frontières and others have launched since the beginning of the epidemic; considers that thealthough the EU was engaged from the very start of the crisis, the response of the Member States has been slow in the beginning; welcomes and encourages in this regard the ongoing scaling-up of the Commission’sEC and MS financial commitment should be stronger in termin the areas of humanitarian and development aid to respond to the crisis; considers it necessary to increase the availability a, logistics and research to respond to the volume of financial resourcecrisis;
2015/02/12
Committee: ENVI
Amendment 94 #
Draft opinion
Paragraph 3 a (new)
3a. Calls on the EU to keep the leadership in fighting the EVD outbreak; stresses that although the efforts invested in containing the outbreak showed significant results, it is necessary to eradicate the disease; in this regards welcomes the high-level international conference on Ebola on 3 March 2015 organized by the EU and key partners with the aim to eradicate Ebola but also to asses the impacts on the affected countries in order to make sure that development aid will build up on humanitarian efforts;
2015/02/12
Committee: ENVI
Amendment 132 #
Motion for a resolution
Paragraph 10
10. Supports the idea of holding a donor conference under the auspices of the United Nations and the European Union with a view to making a swift response to the needs of the countries affectedWelcomes the high-level international conference on Ebola held on 3 March 2015 under the organization of the EU and key partners with the aim of eradicating Ebola but also to assess the impacts on the affected countries in order to make sure that development aid builds up on humanitarian efforts;
2015/05/28
Committee: DEVE
Amendment 150 #
Motion for a resolution
Paragraph 18
18. Calls accordingly on the Commission to step upcontinue the discussions on this issue and to make arrangements for wide- ranging cooperation between the public and private sectors; welcomes in this regard the fact that to address the urgent need for research into new treatments, the EU has made available 138 million euros for projects developing clinical trials for new vaccines, rapid diagnostic tests and treatments under Horizon 2020 and the Innovative Medicines Initiative; commends the European pharmaceutical industry that has also committed important resources to support the research efforts:
2015/05/28
Committee: DEVE